You are in the accessibility menu

Please use this identifier to cite or link to this item:
Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia
  • Universidade Estadual Paulista (UNESP)
  • Massachusetts General Hospital
  • Brigham and Women's Hospital
  • Donald P. Goldstein M.D. Tumor Registry
  • Harvard Cancer Center
  • Harvard Medical School
  • 0090-8258
  • 1095-6859
Objective The purpose of this study was to identify the clinical factors associated with time to hCG remission among women with low-risk postmolar GTN. Methods This study included a non-concurrent cohort of 328 patients diagnosed with low-risk postmolar GTN according to FIGO 2002 criteria. Associations of time to hCG remission with history of prior mole, molar histology, time to persistence, use of D&C at persistence, presence of metastatic disease, FIGO score, hCG values at persistence, type of first line therapy and use of multiagent chemotherapy were investigated with both univariate and multivariate analyses. Results Overall median time to remission was 46 days. Ten percent of the patients required multi-agent chemotherapy to achieve hCG remission. Multivariate analysis incorporating the variables significant on univariate analysis confirmed that complete molar histology (HR 1.45), metastatic disease (HR 1.66), use of multi-agent therapy (HR 2.00) and FIGO score (HR 1.82) were associated with longer time to remission. There was a linear relationship between FIGO score and time to hCG remission. Each 1-point increment in FIGO score was associated with an average 17-day increase in hCG remission time (95% CI: 12.5-21.6). Conclusions Complete mole histology prior to GTN, presence of metastatic disease, use of multi-agent therapy and higher FIGO score were independent factors associated with longer time to hCG remission in low-risk GTN. Identifying the prognostic factors associated with time to remission and effective counseling may help improve treatment planning and reduce anxiety in patients and their families. © 2013 Elsevier Inc. All rights reserved.
Issue Date: 
Gynecologic Oncology, v. 130, n. 2, p. 312-316, 2013.
Time Duration: 
  • Low-risk gestational trophoblastic neoplasia hCG remission Prognostic factors Chemotherapy
  • chorionic gonadotropin
  • adolescent
  • adult
  • cancer chemotherapy
  • child
  • cohort analysis
  • female
  • histopathology
  • human
  • major clinical study
  • metastasis
  • priority journal
  • remission
  • school child
  • trophoblastic tumor
  • Chemotherapy
  • hCG remission
  • Low-risk gestational trophoblastic neoplasia
  • Prognostic factors
  • Adolescent
  • Adult
  • Child
  • Chorionic Gonadotropin
  • Female
  • Gestational Trophoblastic Disease
  • Humans
  • Middle Aged
  • Pregnancy
  • Prognosis
  • Risk
  • Time Factors
Access Rights: 
Acesso restrito
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.